Back to search

Aberrant methylation of FBN2 in human non-small cell lung cancer

Data up to Jan 2025

Published2005
Citations49
References23

Total Citations Per Year

Abstract

References (23)

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

2001 • 607 citations

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

2004 • 344 citations

Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

2000 • 339 citations

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

2003 • 227 citations

Aging, methylation and cancer.

2000 • 209 citations

Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

1995 • 184 citations

Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer versus Small Cell Lung Cancer

2004 • 180 citations

RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells

2004 • 161 citations

Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer

2001 • 146 citations

Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers

2004 • 128 citations

Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.

1999 • 114 citations

Alterations in the mitochondrial displacement loop in lung cancers.

2003 • 99 citations

Molecular Detection of Noninvasive and Invasive Bladder Tumor Tissues and Exfoliated Cells by Aberrant Promoter Methylation of Laminin-5 Encoding Genes

2004 • 86 citations

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

2003 • 80 citations

Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.

2003 • 79 citations

The relationship between aberrant methylation and survival in non-small-cell lung cancers

2004 • 69 citations

Aberrant methylation ofHIN-1 (high in normal-1) is a frequent event in many human malignancies

2004 • 66 citations

Carcinogen exposure differentially modulates RAR- promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis

2003 • 58 citations

Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.

2000 • 46 citations

Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer

1998 • 41 citations

Cloning of Rat Fibrillin-2 cDNA and Its Role in Branching Morphogenesis of Embryonic Lung

1999 • 30 citations

RETRACTED: Aberrant methylation of Reprimo in lung cancer

2004 • 26 citations

Molecular Targets for Cancer Therapy and Prevention

2004 • 13 citations

Cited By (0)

Loading...
Aberrant methylation of FBN2 in human non-small cell lung cancer (2005) – Lung Cancer | Metascience Observatory Explorer